Analyte:
erythromycin; matrix: chemical identification; procedure: infrared absorption spectrophotometry with comparison to standards
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2282 (2008)
Analyte:
erythromycin; matrix: chemical purity; procedure: liquid chromatography with ultraviolet detection at 215 nm and comparison to standards
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.3185 (2008)
Analyte:
erythromycin; matrix: pharmaceutical preparation (delayed-release capsule; delayed-release tablet; injection solution; intramammary infusion; ointment; ophthalmic ointment; tablet; topical gel; topical solution); procedure: thin-layer chromatography with comparison to standards (chemical identification)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2284 (2008)
Analyte:
erythromycin; matrix: pharmaceutical preparation (delayed-release capsule; delayed-release tablet; injection solution; intramammary infusion; pledget; tablet; topical gel; topical solution); procedure: microbial assay (cylinder-plate method) with comparison to standards (chemical purity)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2284 (2008)
Analyte:
erythromycin; matrix: pharmaceutical preparation (ointment); procedure: retention time of the peak in the liquid chromatogram with comparison to standards (chemical identification)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2285 (2008)
Analyte:
erythromycin; matrix: pharmaceutical preparation (ointment); procedure: liquid chromatography with electrochemical detection and comparison to standards (chemical purity)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2285 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2288 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2288 (2008)
Analyte:
erythromycin estolate; matrix: pharmaceutical preparation (capsule; dry mixture for oral suspension; oral suspension; tablet); procedure: thin-layer chromatography with comparison to standards (chemical identification) /
erythromycin estolate/
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2289 (2008)
Analyte:
erythromycin estolate; matrix: pharmaceutical preparation (capsule; dry mixture for oral suspension; oral suspension; tablet); procedure: microbial assay (cylinder-plate method) with comparison to standards (chemical purity) /
erythromycin estolate/
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2289 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2291 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2291 (2008)
Analyte:
erythromycin ethylsuccinate; matrix: pharmaceutical preparation (dry mixture for oral suspension; injection solution; oral suspension; tablet); procedure: microbial assay (cylinder-plate method) with comparison to standards (chemical purity) /
erythromycin ethylsuccinate/
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2292 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2292 (2008)
Analyte:
erythromycin lactobionate; matrix: pharmaceutical preparation (dry mixture for injection solution; sterile solid); procedure: infrared absorption spectrophotometry with comparison to standards (chemical identification) /
erythromycin lactobionate/
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2295 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2295 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2296 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2296 (2008)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2297 (2008)
Analyte:
erythromycin; matrix: pharmaceutical preparation (tablet); procedure: microbial assay (cylinder-plate method) with comparison to standards (chemical purity)
U.S. Pharmacopeia. The United States Pharmacopeia, USP 32/The National Formulary, NF 27; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2297 (2008)
Method: EPA-OW/OST 1694; Procedure: high performance liquid chromatography combined with tandem mass spectrometry; Analyte:
thiabendazole; Matrix:
water, soil, sediment, and biosolids; Detection Limit: 1 ng/L.
National Environmental Methods Index; Analytical, Test and Sampling Methods. Erythromycin (114-07-8). Available from, as of March 12, 2010:
https://www.nemi.gov Method: AOAC 971.48; Procedure: microbiological method; Analyte:
erythromycin; Matrix: feeds; Detection Limit: not provided.
Official Methods of Analysis of AOAC International, 18th Edition Online. Erythromycin (114-07-8). Available from, as of March 15, 2010:
https://www.aoac.org Method: AOAC 988.08; Procedure: microbial receptor assay; Analyte:
erythromycin; Matrix: milk; Detection Limit: 200 ng/mL.
Official Methods of Analysis of AOAC International, 18th Edition Online. Erythromycin (114-07-8). Available from, as of March 15, 2010:
https://www.aoac.org COLORIMETRIC METHOD FOR ESTIMATION OF
ERYTHROMYCIN SALTS IS DESCRIBED.
SANGHAVI NM ET AL; COLORIMETRIC METHOD OF ESTIMATION OF ERYTHROMYCIN; CAN J PHARM SCI 10(2) 59-61 (1975)
VILIM A ET AL; J CHROMATOGR 133(1) 239 (1977)